Literature DB >> 3348302

Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia.

S L Clark1, D B Cotton.   

Abstract

The obstetric literature reflects an increased interest in invasive hemodynamic monitoring during the past decade. While much of this interest has focused on research applications, the patient with severe preeclampsia may benefit clinically from pulmonary artery catheterization under several circumstances. These conditions include severe hypertension unresponsive to conventional antihypertensive therapy, pulmonary edema, persistent oliguria unresponsive to fluid challenge, and in induction of conduction anesthesia in select patients. Theoretical and clinical evidence to support this contention is presented.

Entities:  

Mesh:

Year:  1988        PMID: 3348302     DOI: 10.1016/0002-9378(88)90003-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  European Society of Intensive Care Medicine. Expert panel: the use of the pulmonary artery catheter.

Authors: 
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Hypertension in pregnancy: new recommendations for management.

Authors:  R Shear; L Leduc; E Rey; J M Moutquin
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

3.  Obstetrical anaesthesia for patients with the syndrome of haemolysis, elevated liver enzymes and low platelets.

Authors:  E T Crosby
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

4.  Cardiovascular magnetic resonance in pregnancy: insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study.

Authors:  Robin A Ducas; Jason E Elliott; Steven F Melnyk; Sheena Premecz; Megan daSilva; Kelby Cleverley; Piotr Wtorek; G Scott Mackenzie; Michael E Helewa; Davinder S Jassal
Journal:  J Cardiovasc Magn Reson       Date:  2014-01-03       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.